Ovid Therapeutics Inc. announced the appointment of Alexander Kolevzon, M.D., a leader in child and adolescent psychiatry, to its Scientific Advisory Board (SAB). Dr. Kolevzon is a professor of psychiatry and pediatrics at the Icahn School of Medicine at Mount Sinai. His research focuses on understanding the neurobiology of autism and related neurodevelopmental disorders, biomarker discovery and novel therapeutics. He serves as the director of child and adolescent psychiatry for the Mount Sinai Health System and the clinical director of the Seaver Autism Center for Research and Treatment at Mount Sinai, where he leads the experimental therapeutics program conducting research that ranges from small pilot trials to multi-centered pivotal studies.